MedTrace Logo

A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia

NCT05497817 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-11-17

No results posted yet for this study

Summary

This research is being done to develop a unique matching process for caregivers of persons living with dementia, such as Alzheimer's disease, Lewy body dementia, frontotemporal degeneration, or other dementia syndromes. Dementia caregivers often assume greater caregiving burden than do non-dementia caregivers, and the caregiving duration tends to be longer. Many caregivers do not have the adequate support they need. Peer-to-peer support has been shown to improve quality of life, increase use of services, improve caregiver health, and reduce hospitalizations in the person they are caring for. This study will assess a technology platform and matching process for the purpose of peer-to-peer emotional support aimed at improving overall wellbeing in dementia care partners/caregivers.

Conditions

  • Caregiver Stress
  • Dementia
  • Alzheimer Dementia
  • Lewy Body Dementia
  • Parkinson Disease Dementia
  • Frontotemporal Dementia

Interventions

BEHAVIORAL

Algorithm

Current and/or former Care Partners of persons with dementia will be matched using an algorithm to other Care Partners who might provide emotional support.

BEHAVIORAL

Random Match

Current and/or former Care Partners of persons with dementia will be randomly matched to other Care Partners who might provide emotional support.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Minnesota HealthSolutions

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Julie Fields, PhD, LP · Mayo Clinic

  • Kevin Kramer, PhD · Minnesota HealthSolutions, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2024-09-30
Completion
2024-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05497817 on ClinicalTrials.gov